Impact of comorbidity on outcome of older breast cancer patients: A FOCUS cohort study

Breast Cancer Research and Treatment

Volumn 145, Issue 1, 2014, Pages 185-192

  Kiderlen, Mandy ^a   De Glas, Nienke A ^a   Bastiaannet, Esther ^a   Van De Water, Willemien ^a   De Craen, Anton J M ^a   Guicherit, Onno R ^b   Merkus, Jos W S ^c   Extermann, Martine ^d   Van De Velde, Cornelis J H ^a   Liefers, Gerrit Jan ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MEDICAL CENTER HAAGLANDEN   (Netherlands)

^c HAGA HOSPITAL   (Netherlands)

^d H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Breast cancer; Comorbidity; Distant recurrence; Epidemiology; Geriatric oncology; Overall survival

Indexed keywords

AGED; ARTICLE; BREAST CANCER; CANCER RISK; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISTANT METASTASIS; FEMALE; FOLLOW UP; GERIATRIC PATIENT; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; RISK ASSESSMENT; RISK FACTOR; VERY ELDERLY; BREAST NEOPLASMS;

AGED; BREAST NEOPLASMS; COHORT STUDIES; COMORBIDITY; FEMALE; HUMANS;

EID: 84900514535     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-014-2917-7     Document Type: Article

References (31)

1. Wildiers H, Kunkler I, Biganzoli L et al (2007) Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology. Lancet Oncol 8:1101-1115
2. Biganzoli L, Wildiers H, Oakman C et al (2012) Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA). Lancet Oncol 13:e148-e160
3. Wildiers H, Mauer M, Pallis A et al (2013) End points and trial design in geriatric oncology research: a joint European organisation for research and treatment of cancer - Alliance for Clinical Trials in Oncology-International Society of Geriatric Oncology position article. J Clin Oncol 31:3711-3718
4. Mell LK, Jeong JH, Nichols MA et al (2010) Predictors of competing mortality in early breast cancer. Cancer 116:5365-5373
5. van de Water W, Markopoulos C, van de Velde CJ et al (2012) Association between age at diagnosis and disease-specific mortality among postmenopausal women with hormone receptor-positive breast cancer. JAMA 307:590-597
6. Schairer C, Mink PJ, Carroll L et al (2004) Probabilities of death from breast cancer and other causes among female breast cancer patients. J Natl Cancer Inst 96:1311-1321
7. Yancik R, Wesley MN, Ries LA et al (2001) Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA 285:885-892
8. van de Water W, Seynaeve C, Bastiaannet E et al (2013) Elderly postmenopausal patients with breast cancer are at increased risk for distant recurrence: a tamoxifen exemestane adjuvant multinational study analysis. Oncologist 18:8-13
9. Barnett K, Mercer SW, Norbury M et al (2012) Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet 380:37-43
10. Al-Refaie WB, Vickers SM, Zhong W et al (2011) Cancer trials versus the real world in the United States. Ann Surg 254:438-442
11. Hutchins LF, Unger JM, Crowley JJ et al (1999) Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med 341:2061-2067
12. World Health Organization (2012) The international statistical classification of diseases and related health problems ICD-10
13. Conference communication: age categorization proposed at oral session, accessible for members only. Discussed at: International Society of Geriatric Oncology annual meeting; Berlin, Germany, 15-17 Oct 2009
14. Patnaik JL, Byers T, Diguiseppi C et al (2011) The influence of comorbidities on overall survival among older women diagnosed with breast cancer. J Natl Cancer Inst 103:1101-1111
15. Land LH, Dalton SO, Jensen MB et al (2012) Impact of comorbidity on mortality: a cohort study of 62,591 Danish women diagnosed with early breast cancer, 1990-2008. Breast Cancer Res Treat 131:1013-1020
16. Ording AG, Cronin-Fenton DP, Jacobsen JB et al (2013) Comorbidity and survival of Danish breast cancer patients from 2000-2011: a population-based cohort study. Clin Epidemiol 5:39-46
17. Patnaik JL, Byers T, Diguiseppi C et al (2011) Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study. Breast Cancer Res 13:R64
18. Siegelmann-Danieli N, Khandelwal V, Wood GC et al (2006) Breast cancer in elderly women: outcome as affected by age, tumor features, comorbidities, and treatment approach. Clin Breast Cancer 7:59-66
19. Janssen-Heijnen ML, Houterman S, Lemmens VE et al (2005) Prognostic impact of increasing age and co-morbidity in cancer patients: a population-based approach. Crit Rev Oncol Hematol 55:231-240
20. Janssen-Heijnen MLG, Szerencsi K, van de Schans SAM et al (2010) Cancer patients with cardiovascular disease have survival rates comparable to cancer patients within the age-cohort of 10 years older without cardiovascular morbidity. Crit Rev Oncol Hematol 76:196-207
21. Houterman S, Janssen-Heijnen ML, Verheij CD et al (2004) Comorbidity has negligible impact on treatment and complications but influences survival in breast cancer patients. Br J Cancer 90:2332-2337
22. Ring A, Sestak I, Baum M et al (2011) Influence of comorbidities and age on risk of death without recurrence: a retrospective analysis of the Arimidex, Tamoxifen alone or in combination trial. J Clin Oncol 29:4266-4272
23. Harris EE, Hwang WT, Urtishak SL et al (2008) The impact of comorbidities on outcomes for elderly women treated with breast-conservation treatment for early-stage breast cancer. Int J Radiat Oncol Biol Phys 70:1453-1459
24. Louwman WJ, Janssen-Heijnen ML, Houterman S et al (2005) Less extensive treatment and inferior prognosis for breast cancer patient with comorbidity: a population-based study. Eur J Cancer 41:779-785
25. Pal SK, Katheria V, Hurria A (2010) Evaluating the older patient with cancer: understanding frailty and the geriatric assessment. CA Cancer J Clin 60:120-132
26. Hamaker ME, Jonker JM, de Rooij SE et al (2012) Frailty screening methods for predicting outcome of a comprehensive geriatric assessment in elderly patients with cancer: a systematic review. Lancet Oncol 13:e437-e444
27. Raji MA, Kuo Y-F, Freeman JL et al (2008) Effect of a dementia diagnosis on survival of older patients after a diagnosis of breast, colon, or prostate cancer: implications for cancer care. Arch Intern Med 168:2033-2040
28. Robb C, Boulware D, Overcash J et al (2010) Patterns of care and survival in cancer patients with cognitive impairment. Crit Rev Oncol Hematol 74:218-224
29. Ording AG, Garne JP, Nystrom PM et al (2013) Comorbid diseases interact with breast cancer to affect mortality in the first year after diagnosis - a Danish nationwide matched cohort study. PLoS One 8:e76013
30. Hamaker ME, Hamelinck VC, van Munster BC et al (2012) Nonreferral of nursing home patients with suspected breast cancer. J Am Med Dir Assoc 13:464-469
31. Lin TL, Kuo MC, Shih LY et al (2012) The impact of age, Charlson comorbidity index, and performance status on treatment of elderly patients with diffuse large B cell lymphoma. Ann Hematol 91:1383-1391